SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-24-001096
Filing Date
2024-11-12
Accepted
2024-11-12 16:04:09
Documents
81
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q igc20240930_10q.htm   iXBRL 10-Q 1165990
2 EXHIBIT 31.1 ex_744558.htm EX-31.1 14289
3 EXHIBIT 31.2 ex_744559.htm EX-31.2 14483
4 EXHIBIT 32.1 ex_744560.htm EX-32.1 7583
10 igc20240930_10qimg001.jpg GRAPHIC 1860
11 igc20240930_10qimg002.jpg GRAPHIC 1281
  Complete submission text file 0001185185-24-001096.txt   6229843

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA igc-20240930.xsd EX-101.SCH 47824
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE igc-20240930_cal.xml EX-101.CAL 41852
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20240930_def.xml EX-101.DEF 213738
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20240930_lab.xml EX-101.LAB 383436
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20240930_pre.xml EX-101.PRE 227917
83 EXTRACTED XBRL INSTANCE DOCUMENT igc20240930_10q_htm.xml XML 1034388
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-32830 | Film No.: 241447882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)